PRIMA

Science Corporation implants PRIMA vision chip in first Stargardt patient

Science Corporation said its vision-restoring chip PRIMA was implanted in the first patient with Stargardt disease, an incurable inherited eye condition that has blinded about 150,000 people worldwide. CEO Max Hodak, at TechCrunch Disrupt, said the retina is part of the central nervous system and retinal prostheses are a form of brain-computer interface, as the company pursues broader medical BCI uses.